Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Cole R. Steber, Gregory B. Russell, Marie C. Rush, Rachel F. Shenker, Bart. A. Frizzell, Kathryn M. Greven & Ryan T. Hughes. (2022) Timing of radiotherapy and chemotherapy start for patients treated with definitive concurrent chemoradiation for head and neck cancer. Acta Oncologica 61:8, pages 987-993.
Read now
Read now
Articles from other publishers (13)
Qiu-Xia Peng, Yun-Wei Han, Yan-Ling Zhang, Jie Hu, Juan Fan, Shao-Zhi Fu, Shan Xu & Qiang Wan. (2017)
Apatinib inhibits VEGFR-2 and angiogenesis in an
in vivo
murine model of nasopharyngeal carcinoma
. Oncotarget 8:32, pages 52813-52822.
Crossref
Crossref
Guanghui Wang, Shujing Wang & Congying Li. (2017) MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma. Tumor Biology 39:6, pages 101042831770382.
Crossref
Crossref
Rami Abdou & Soly Baredes. (2017) Population-Based Results in the Management of Sinonasal and Ventral Skull Base Malignancies. Otolaryngologic Clinics of North America 50:2, pages 481-497.
Crossref
Crossref
Long-Hui Cao, Hui-Ting Li, Wen-Qian Lin, Hong-Ying Tan, Lan Xie, Zhong-Jian Zhong & Jian-Hua Zhou. (2016) Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts. Scientific Reports 6:1.
Crossref
Crossref
Xiaohua Feng, Qianbing Zhang, Songxin Xia, Bing Xia, Yue Zhang, Xubin Deng, Wenmei Su & Jianqing Huang. (2014) MTA1 Overexpression Induces Cisplatin Resistance Innasopharyngeal Carcinoma by Promoting Cancer Stem Cells Properties. Molecules and Cells 37:9, pages 699-704.
Crossref
Crossref
Alejandro Vazquez, Mohemmed N. Khan, Satish Govindaraj, Soly Baredes & Jean Anderson Eloy. (2014) Nasopharyngeal squamous cell carcinoma: a comparative analysis of keratinizing and nonkeratinizing subtypes. International Forum of Allergy & Rhinology 4:8, pages 675-683.
Crossref
Crossref
Tanadech Dechaphunkul, Kowit Pruegsanusak, Duangjai Sangthawan & Patrapim Sunpaweravong. (2011) Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5- fluorouracil in locally advanced nasopharyngeal carcinoma. Head & Neck Oncology 3:1.
Crossref
Crossref
Loredana G. Marcu & E. Yeoh. (2009) A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment. Journal of Cancer Research and Clinical Oncology 135:10, pages 1303-1314.
Crossref
Crossref
Kazim Uygun, Ahmet Bilici, Hakan Karagol, Murat Caloglu, Irfan Cicin, Gorkem Aksu, Merdan Fayda & Sernaz Uzunoglu. (2009) The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck. Cancer Chemotherapy and Pharmacology 64:3, pages 601-605.
Crossref
Crossref
L.G. MARCU. (2009) The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy. European Journal of Cancer Care 18:2, pages 116-123.
Crossref
Crossref
G. Noël, B. Dessard-Diana, S. Vignot & J.J. Mazeron. (2002) Les traitements des cancers du nasopharynx : revue de la littérature. Cancer/Radiothérapie 6:2, pages 59-84.
Crossref
Crossref
Guolin Tan, Li Heqing, Chen Jiangbo, Jiang Ming, Ma Yanhong, Liu Xianghe, Sun Hong & Guiyuan Li. (2001) Apoptosis induced by low‐dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells. International Journal of Cancer 97:2, pages 168-172.
Crossref
Crossref
Haldun Ş Erkal, Meltem Serin & Ahmet Çakmak. (2001) Nasopharyngeal carcinomas: analysis of patient, tumor and treatment characteristics determining outcome. Radiotherapy and Oncology 61:3, pages 247-256.
Crossref
Crossref